Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Arvinas Inc (ARVN)

Arvinas Inc (ARVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response Newswire.ca - Tue Apr 30, 9:30AM CDT

/CNW/ -- USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In...

ONCY : 1.0100 (+2.02%)
ICCM : 0.7393 (-0.27%)
ATOS : 1.1700 (+0.86%)
ARVN : 23.90 (-3.82%)
PFE : 27.70 (-0.47%)
ONC.TO : 1.41 (+2.92%)
Biotech Firms Intensify Efforts as Breast Cancer Strikes Younger Patients at Alarming Rate BayStreet.ca - Tue Apr 30, 9:04AM CDT

USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In particular, a surge in cases of breast cancer is...

ONCY : 1.0100 (+2.02%)
ONC.TO : 1.41 (+2.92%)
ICCM : 0.7393 (-0.27%)
ATOS : 1.1700 (+0.86%)
ARVN : 23.90 (-3.82%)
PFE : 27.70 (-0.47%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer BayStreet.ca - Wed Feb 7, 8:06AM CST

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

ONCY : 1.0100 (+2.02%)
ONC.TO : 1.41 (+2.92%)
PFE : 27.70 (-0.47%)
ARVN : 23.90 (-3.82%)
OLMA : 10.67 (+2.50%)
AZN : 76.80 (-0.25%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer BayStreet.ca - Thu Dec 7, 2023

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

AVRN : 0.0125 (-30.56%)
ONCY : 1.0100 (+2.02%)
ONC.TO : 1.41 (+2.92%)
PFE : 27.70 (-0.47%)
ARVN : 23.90 (-3.82%)
OLMA : 10.67 (+2.50%)
AZN : 76.80 (-0.25%)
Arvinas and Quantum Leap Healthcare Announce Clinical Study to Evaluate Vepdegestrant (ARV-471) in I-SPY-2 Endocrine Optimization Platform (EOP) Clinical Trial PR Newswire - Tue May 2, 2023

/PRNewswire/ -- Arvinas, Inc. (Nasdaq: ARVN) and Quantum Leap Healthcare Collaborative™ today announced that Arvinas' vepdegestrant (ARV-471), a novel PROTAC®...

ARVN : 23.90 (-3.82%)
Author
3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023 MarketBeat - Fri Jan 13, 2023

Health care stocks are trying to make a comeback and these three small-cap biopharma companies are leading the charge in some ways.

ARVN : 23.90 (-3.82%)
RCKT : 20.03 (+1.26%)
XNCR : 18.61 (+1.92%)
Jon Soderstrom Joins Wilson Sonsini as Chief Licensing Advisor Business Wire - Mon Nov 28, 2022

Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, announced today that Jon Soderstrom is joining the firm as its chief...

ACHN : 0.7912 (-21.66%)
ARVN : 23.90 (-3.82%)
NXTC : 1.5700 (+4.67%)
BHVN : 33.79 (-1.11%)
INZY : 4.49 (+1.58%)
Arvinas Reports Second Quarter 2022 Financial Results and Provides Corporate Update Globe Newswire - Thu Aug 4, 2022

NEW HAVEN, Conn., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...

ARVN : 23.90 (-3.82%)
Arvinas Appoints John Northcott as Chief Commercial Officer Globe Newswire - Mon Aug 1, 2022

NEW HAVEN, Conn., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...

ARVN : 23.90 (-3.82%)
Arvinas to Present at Goldman Sachs 43rd Annual Global Healthcare Conference Globe Newswire - Thu Jun 2, 2022

NEW HAVEN, Conn., June 02, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...

ARVN : 23.90 (-3.82%)

Barchart Exclusives

3 Mid-Cap Energy Dividend Stocks to Scoop Up Now Barchart - Wed Jul 3, 6:30PM CDT
Amid predictions of higher oil prices, here are three dividend-paying energy stocks that are worth adding to your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot